vimarsana.com

Latest Breaking News On - Schwab investment management - Page 1 : vimarsana.com

Covenant Partners LLC Increases Position in iShares Russell 1000 Value ETF (NYSEARCA:IWD)

Covenant Partners LLC grew its position in shares of iShares Russell 1000 Value ETF (NYSEARCA:IWD – Free Report) by 2.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 137,027 shares of the exchange traded fund’s stock after buying an additional 3,673 shares during […]

Covenant Partners LLC Increases Position in iShares Russell 1000 Value ETF (NYSEARCA:IWD)

Covenant Partners LLC grew its position in shares of iShares Russell 1000 Value ETF (NYSEARCA:IWD – Free Report) by 2.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 137,027 shares of the exchange traded fund’s stock after buying an additional 3,673 shares during […]

Cisco Systems, Inc (NASDAQ:CSCO) EVP Deborah L Stahlkopf Sells 2,619 Shares

Cisco Systems, Inc. (NASDAQ:CSCO – Get Free Report) EVP Deborah L. Stahlkopf sold 2,619 shares of Cisco Systems stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $45.34, for a total transaction of $118,745.46. Following the sale, the executive vice president now owns 176,384 shares […]

StockNews com Downgrades National Presto Industries (NYSE:NPK) to Hold

National Presto Industries (NYSE:NPK – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Friday. National Presto Industries Price Performance Shares of NYSE:NPK traded down $1.36 during trading on Friday, hitting $74.23. 56,883 shares of the company were exchanged, […]

13,078 Shares in Pfizer Inc (NYSE:PFE) Purchased by Prospect Financial Services LLC

Prospect Financial Services LLC purchased a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 13,078 shares of the biopharmaceutical company’s stock, valued at approximately $377,000. Other hedge funds and other institutional investors […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.